Text Size
863 studies found for:    "Macular Degeneration"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"Macular Degeneration"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments
Conditions: Age-related Macular Degeneration;   Pigment Epithelial Detachment;   Neovascular Macular Degeneration;   Wet Macular Degeneration
Intervention: Drug: ranibizumab
2 Active, not recruiting Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Conditions: Age-Related Macular Degeneration;   Wet Age-Related Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
3 Completed
Has Results 		Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Age-related Macular Degeneration;   Neovascular Macular Degeneration
Intervention: Drug: Pegaptanib
4 Recruiting An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Wet Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
5 Active, not recruiting HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Conditions: Wet Macular Degeneration;   Macular Degeneration;   Pigment Epithelium of Eye;   Retinal Detachment
Intervention: Drug: ranibizumab
6 Terminated
Has Results 		The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Conditions: Choroidal Neo-Vascular Age-onset Macular Degeneration;   Age-related Macular Degeneration
Interventions: Drug: Everolimus;   Drug: Ranibizumab
7 Recruiting Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
Conditions: Neovascular Age-elated Macular Degeneration (Wet AMD);   Exudative Macular Degeneration
Interventions: Drug: LFG316;   Drug: Placebo
8 Recruiting Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Macular Degeneration
Interventions: Drug: Intravitreal Aflibercept Injection More;   Drug: Intravitreal Aflibercept Injection Less
9 Recruiting Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
Conditions: Age Related Macular Degeneration;   Macular Degeneration;   AMD
Intervention: Drug: HuCNS-SC cells
10 Withdrawn Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
Conditions: Wet Age-related Macular Degeneration;   Age-related Macular Degeneration;   AMD;   Wet AMD;   Macular Degeneration
Intervention: Device: IRay
11 Active, not recruiting INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
Conditions: AMD;   Wet AMD;   Age-Related Macular Degeneration;   Wet Age-Related Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
12 Terminated A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Conditions: Age Related Macular Degeneration;   Choroidal Neovascular Membrane;   Subfoveal Neovascular Age-Related Macular Degeneration;   Macular Degeneration;   Wet Age-Related Macular Degeneration
Intervention: Drug: Ranibizumab
13 Terminated
Has Results 		An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD
Conditions: Age Related Macular Degeneration (AMD);   Macular Degeneration;   Choroidal Neovascularization (CNV)
Intervention: Drug: Pegaptanib Sodium 0.3 mg
14 Withdrawn Combination Therapy for Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: intravitreal bevacizumab and triamcinolone acetonide
15 Completed Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: pazopanib eye drops;   Drug: placebo;   Biological: ranibizumab intravitreal injection
16 Active, not recruiting High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention:
17 Recruiting Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Age-related Maculopathies;   Age-related Maculopathy;   Maculopathies,Age-related;   Maculopathy,Age-related;   Retinal Degeneration;   Retinal Neovascularization;   Eye Diseases
Interventions: Biological: rAAV.sFlt-1;   Other: Control (ranibizumab alone)
18 Recruiting Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Microplasmin;   Drug: Placebo control
19 Completed Systemic Avastin Therapy in Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Bevacizumab;   Drug: Sodium Chloride
20 Completed Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: pegaptanib sodium
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years